Financials

  • Market Capitalization 1.81 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.15
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2057
NTLA
Intellia Therapeutics, Inc. - Common Stock
13.04 USD-1.95%-22.57%-11.71%-4.96%1.82 B USD
2059
SRPT
Sarepta Therapeutics, Inc. - Common Stock
17.61 USD-1.95%-12.86%+11.67%-3.77%1.86 B USD
2075
ZYME
Zymeworks Inc. - Common Stock
24.67 USD+0.04%-7.43%+5.88%+39.06%1.80 B USD
2088
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.31 USD-0.90%-11.02%+1.22%-37.43%1.75 B USD